NYSE:ALC Alcon Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Alcon AG Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $56.89 +0.09 (+0.16 %) (As of 09/29/2020 12:00 AM ET) Add Compare Share Today's Range$56.57Now: $56.89▼$57.5950-Day Range$55.23MA: $58.10▼$61.9652-Week Range$39.37Now: $56.89▼$65.37Volume823,908 shsAverage Volume1.35 million shsMarket Capitalization$27.77 billionP/E RatioN/ADividend YieldN/ABeta0.52 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Alcon, Inc. develops and manufactures eye care products for eye care professionals and their patients. It offers surgical products, which include technologies and devices for cataract, retinal, glaucoma, and refractive surgery; advanced technology intraocular lenses to treat cataracts and refractive errors, such as presbyopia and astigmatism; and advanced viscoelastics, surgical solutions, surgical packs, and other disposable products for cataract and vitreoretinal surgery. The company also provides pharmaceutical products for elevated intraocular pressure caused by glaucoma; anti-inflammatories; anti-infective to aid in the treatment of bacterial infections and bacterial conjunctivitis; ophthalmic solutions to treat inflammation and pain associated with ocular surgery; eye inflammation and infection solutions following cataract surgery; and vitreomacular adhesion, eye and nasal allergy treatment solutions, and over-the-counter dry eye relief and ocular vitamins. In addition, it offers vision care products, such as contact lenses and lens care products; daily disposable, monthly replacement, and color-enhancing contact lenses for comfortable and convenient vision correction options; contact lens care products; multi-purpose and hydrogen-peroxide based solutions to clean, rinse, and disinfect contact lenses; rewetting drops; and daily protein removers that removes protein deposits from lenses. Alcon, Inc. was formerly known as Alcon Universal S.A. and changed the name to Alcon, Inc. in December 2001. The company was founded in 1945 and is based in Fort Worth, Texas. Alcon, Inc. was previously operating as a subsidiary of Novartis AG. Alcon, Inc.(SWX:ALC) operates independently of Novartis AG as of April 9, 2019.Read More Beat the Market (BTM) Rank™ 2.1 Analyst's Opinion Consensus RatingAlcon has received a consensus rating of Hold. The company's average rating score is 2.24, and is based on 8 buy ratings, 5 hold ratings, and 4 sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $59.78, Alcon has a forecasted upside of 5.1% from its current price of $56.89.Amount of Analyst CoverageAlcon has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 2.4 Community Rank Outperform VotesAlcon has received 111 “outperform” votes. (Add your “outperform” vote.)Underperform VotesAlcon has received 119 “underperform” votes. (Add your “underperform” vote.)Community SentimentAlcon has received 51.74% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Alcon and other stocks. Vote “Outperform” if you believe ALC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ALC will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldAlcon does not currently pay a dividend.Dividend GrowthAlcon does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Alcon insiders have not sold or bought any company stock.Percentage Held by Institutions49.82% of the stock of Alcon is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Alcon are expected to grow by 120.93% in the coming year, from $0.86 to $1.90 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Alcon is -43.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alcon is -43.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioAlcon has a PEG Ratio of 7.83. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioAlcon has a P/B Ratio of 1.44. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 2.1Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.48 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Ophthalmic goods Sub-IndustryHealth Care Facilities SectorMedical Current SymbolNYSE:ALC Previous Symbol CUSIP04544X30 CIK929994 Webwww.alcon.com Phone41-58-911-2000Debt Debt-to-Equity Ratio0.22 Current Ratio2.23 Quick Ratio1.43Price-To-Earnings Trailing P/E RatioN/A Forward P/E Ratio66.15 P/E Growth7.83 Sales & Book Value Annual Sales$7.51 billion Price / Sales3.70 Cash Flow$4.93 per share Price / Cash Flow11.54 Book Value$39.54 per share Price / Book1.44Profitability EPS (Most Recent Fiscal Year)$1.89 Net Income$-656,000,000.00 Net Margins-9.30% Return on Equity2.94% Return on Assets2.05%Miscellaneous Employees22,142 Outstanding Shares488,200,000Market Cap$27.77 billion Next Earnings Date11/17/2020 (Estimated) OptionableNot Optionable $56.89 +0.09 (+0.16 %) (As of 09/29/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive ALC News and Ratings via Email Sign-up to receive the latest news and ratings for ALC and its competitors with MarketBeat's FREE daily newsletter. Alcon (NYSE:ALC) Frequently Asked Questions How has Alcon's stock been impacted by COVID-19? Alcon's stock was trading at $54.20 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ALC stock has increased by 5.0% and is now trading at $56.89. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Alcon? 17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alcon in the last year. There are currently 4 sell ratings, 5 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Alcon. When is Alcon's next earnings date? Alcon is scheduled to release its next quarterly earnings announcement on Tuesday, November 17th 2020. View our earnings forecast for Alcon. How were Alcon's earnings last quarter? Alcon AG (NYSE:ALC) released its quarterly earnings results on Tuesday, August, 18th. The healthcare company reported ($0.21) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.15) by $0.06. The healthcare company had revenue of $1.20 billion for the quarter, compared to analysts' expectations of $1.21 billion. Alcon had a positive return on equity of 2.94% and a negative net margin of 9.30%. Alcon's quarterly revenue was down 35.7% on a year-over-year basis. View Alcon's earnings history. What price target have analysts set for ALC? 17 equities research analysts have issued twelve-month target prices for Alcon's shares. Their forecasts range from $50.00 to $68.00. On average, they expect Alcon's share price to reach $59.78 in the next year. This suggests a possible upside of 5.1% from the stock's current price. View analysts' price targets for Alcon. Are investors shorting Alcon? Alcon saw a decrease in short interest in the month of September. As of September 15th, there was short interest totaling 5,620,000 shares, a decrease of 16.4% from the August 31st total of 6,720,000 shares. Based on an average trading volume of 1,280,000 shares, the short-interest ratio is presently 4.4 days. Approximately 1.2% of the company's stock are short sold. View Alcon's Short Interest. Who are some of Alcon's key competitors? Some companies that are related to Alcon include HCA Healthcare (HCA), Universal Health Services (UHS), The Ensign Group (ENSG), Select Medical (SEM), Acadia Healthcare (ACHC), Tenet Healthcare (THC), U.S. Physical Therapy (USPH), National HealthCare (NHC), Hanger (HNGR), Community Health Systems (CYH), Brookdale Senior Living (BKD), Five Star Senior Living (FVE), Capital Senior Living (CSU) and Encompass Health (EHC). View all competitors. What other stocks do shareholders of Alcon own? Based on aggregate information from My MarketBeat watchlists, some companies that other Alcon investors own include AT&T (T), Novartis (NVS), Verizon Communications (VZ), IBM (IBM), Intel (INTC), Pfizer (PFE), Cisco Systems (CSCO), Johnson & Johnson (JNJ), AbbVie (ABBV) and Chevron (CVX). Who are Alcon's key executives? Alcon's management team includes the following people: Mr. Merrick McCracken, Sr. VP of HRMr. Ed McGough, Sr. VP of Global Manufacturing and Technical Operations (Age 58)Mr. David J. Endicott, Chief Exec. Officer (Age 54)Mr. David Murray, Chief Financial OfficerMr. Allen Baker, Chief Operating Officer and Exec. VP What is Alcon's stock symbol? Alcon trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALC." How do I buy shares of Alcon? Shares of ALC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Alcon's stock price today? One share of ALC stock can currently be purchased for approximately $56.89. How big of a company is Alcon? Alcon has a market capitalization of $27.77 billion and generates $7.51 billion in revenue each year. The healthcare company earns $-656,000,000.00 in net income (profit) each year or $1.89 on an earnings per share basis. Alcon employs 22,142 workers across the globe. What is Alcon's official website? The official website for Alcon is www.alcon.com. How can I contact Alcon? Alcon's mailing address is Rue Louis-d`Affry 6, Fribourg V8, 1701. The healthcare company can be reached via phone at 41-58-911-2000 or via email at [email protected] This page was last updated on 9/29/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
